Literature DB >> 23644467

The collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to facilitate breast cancer metastasis.

Kun Zhang1, Callie A Corsa, Suzanne M Ponik, Julie L Prior, David Piwnica-Worms, Kevin W Eliceiri, Patricia J Keely, Gregory D Longmore.   

Abstract

Increased stromal collagen deposition in human breast tumours correlates with metastases. We show that activation of the collagen I receptor DDR2 (discoidin domain receptor 2) regulates SNAIL1 stability by stimulating ERK2 activity, in a Src-dependent manner. Activated ERK2 directly phosphorylates SNAIL1, leading to SNAIL1 nuclear accumulation, reduced ubiquitylation and increased protein half-life. DDR2-mediated stabilization of SNAIL1 promotes breast cancer cell invasion and migration in vitro, and metastasis in vivo. DDR2 expression was observed in most human invasive ductal breast carcinomas studied, and was associated with nuclear SNAIL1 and absence of E-cadherin expression. We propose that DDR2 maintains SNAIL1 level and activity in tumour cells that have undergone epithelial-mesenchymal transition (EMT), thereby facilitating continued tumour cell invasion through collagen-I-rich extracellular matrices by sustaining the EMT phenotype. As such, DDR2 could be an RTK (receptor tyrosine kinase) target for the treatment of breast cancer metastasis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23644467      PMCID: PMC3794710          DOI: 10.1038/ncb2743

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  40 in total

Review 1.  Mammary gland ECM remodeling, stiffness, and mechanosignaling in normal development and tumor progression.

Authors:  Pepper Schedin; Patricia J Keely
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-01-01       Impact factor: 10.005

2.  Temporal and spatial cooperation of Snail1 and Twist1 during epithelial-mesenchymal transition predicts for human breast cancer recurrence.

Authors:  David D Tran; Callie Ann S Corsa; Hirak Biswas; Rebecca L Aft; Gregory D Longmore
Journal:  Mol Cancer Res       Date:  2011-10-17       Impact factor: 5.852

3.  Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation.

Authors:  C Desbois-Mouthon; A Cadoret; M J Blivet-Van Eggelpoël; F Bertrand; G Cherqui; C Perret; J Capeau
Journal:  Oncogene       Date:  2001-01-11       Impact factor: 9.867

4.  Discoidin domain receptor 2 interacts with Src and Shc following its activation by type I collagen.

Authors:  Kazuo Ikeda; Li-Hsien Wang; Richard Torres; Hong Zhao; Elvira Olaso; Francis J Eng; Pablo Labrador; Rudiger Klein; David Lovett; George D Yancopoulos; Scott L Friedman; Hsin Chieh Lin
Journal:  J Biol Chem       Date:  2002-03-07       Impact factor: 5.157

5.  Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction.

Authors:  Donald E White; Natasza A Kurpios; Dongmei Zuo; John A Hassell; Sandra Blaess; Ulrich Mueller; William J Muller
Journal:  Cancer Cell       Date:  2004-08       Impact factor: 31.743

6.  Role of discoidin domain receptors 1 and 2 in human smooth muscle cell-mediated collagen remodeling: potential implications in atherosclerosis and lymphangioleiomyomatosis.

Authors:  Nicola Ferri; Neil O Carragher; Elaine W Raines
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

7.  Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis.

Authors:  Jing Yang; Sendurai A Mani; Joana Liu Donaher; Sridhar Ramaswamy; Raphael A Itzykson; Christophe Come; Pierre Savagner; Inna Gitelman; Andrea Richardson; Robert A Weinberg
Journal:  Cell       Date:  2004-06-25       Impact factor: 41.582

8.  The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.

Authors:  Ethan Cerami; Jianjiong Gao; Ugur Dogrusoz; Benjamin E Gross; Selcuk Onur Sumer; Bülent Arman Aksoy; Anders Jacobsen; Caitlin J Byrne; Michael L Heuer; Erik Larsson; Yevgeniy Antipin; Boris Reva; Arthur P Goldberg; Chris Sander; Nikolaus Schultz
Journal:  Cancer Discov       Date:  2012-05       Impact factor: 39.397

9.  EGF-R signaling through Fyn kinase disrupts the function of integrin alpha6beta4 at hemidesmosomes: role in epithelial cell migration and carcinoma invasion.

Authors:  A Mariotti; P A Kedeshian; M Dans; A M Curatola; L Gagnoux-Palacios; F G Giancotti
Journal:  J Cell Biol       Date:  2001-10-29       Impact factor: 10.539

Review 10.  The complexities of breast cancer desmoplasia.

Authors:  R A Walker
Journal:  Breast Cancer Res       Date:  2001-02-01       Impact factor: 6.466

View more
  178 in total

Review 1.  Integrated extracellular matrix signaling in mammary gland development and breast cancer progression.

Authors:  Jieqing Zhu; Gaofeng Xiong; Christine Trinkle; Ren Xu
Journal:  Histol Histopathol       Date:  2014-03-28       Impact factor: 2.303

2.  Discoidin domain receptor 1 is a novel transcriptional target of ZEB1 in breast epithelial cells undergoing H-Ras-induced epithelial to mesenchymal transition.

Authors:  Minsoo Koh; Yunjung Woo; Rajeshwari R Valiathan; Hae Yoen Jung; So Yeon Park; Yong Nyun Kim; Hyeong-Reh Choi Kim; Rafael Fridman; Aree Moon
Journal:  Int J Cancer       Date:  2014-08-30       Impact factor: 7.396

Review 3.  The emerging role of Snail1 in the tumor stroma.

Authors:  A Herrera; M Herrera; C Peña
Journal:  Clin Transl Oncol       Date:  2015-12-21       Impact factor: 3.405

4.  Tyrosine kinase discoidin domain receptors DDR1 and DDR2 are coordinately deregulated in triple-negative breast cancer.

Authors:  Kathy A Toy; Rajeshwari R Valiathan; Fernando Núñez; Kelley M Kidwell; Maria E Gonzalez; Rafael Fridman; Celina G Kleer
Journal:  Breast Cancer Res Treat       Date:  2015-02-10       Impact factor: 4.872

5.  Mesenchymal Stem Cell-Induced DDR2 Mediates Stromal-Breast Cancer Interactions and Metastasis Growth.

Authors:  Maria E Gonzalez; Emily E Martin; Talha Anwar; Caroline Arellano-Garcia; Natasha Medhora; Arjun Lama; Yu-Chih Chen; Kevin S Tanager; Euisik Yoon; Kelley M Kidwell; Chunxi Ge; Renny T Franceschi; Celina G Kleer
Journal:  Cell Rep       Date:  2017-01-31       Impact factor: 9.423

6.  Targeting of Discoidin Domain Receptor 2 (DDR2) Prevents Myofibroblast Activation and Neovessel Formation During Pulmonary Fibrosis.

Authors:  Hu Zhao; Huan Bian; Xin Bu; Shuya Zhang; Pan Zhang; Jiangtian Yu; Xiaofeng Lai; Di Li; Chuchao Zhu; Libo Yao; Jin Su
Journal:  Mol Ther       Date:  2016-05-27       Impact factor: 11.454

7.  Kir2.1 Interaction with Stk38 Promotes Invasion and Metastasis of Human Gastric Cancer by Enhancing MEKK2-MEK1/2-ERK1/2 Signaling.

Authors:  Cheng-Dong Ji; Yan-Xia Wang; Dong-Fang Xiang; Qiang Liu; Zhi-Hua Zhou; Feng Qian; Lang Yang; Yong Ren; Wei Cui; Sen-Lin Xu; Xi-Long Zhao; Xia Zhang; Yan Wang; Peng Zhang; Ji-Ming Wang; You-Hong Cui; Xiu-Wu Bian
Journal:  Cancer Res       Date:  2018-03-16       Impact factor: 12.701

8.  Overexpression of DDR2 contributes to cell invasion and migration in head and neck squamous cell carcinoma.

Authors:  Jinke Xu; Wei Lu; Senlin Zhang; Chuchao Zhu; Tingting Ren; Tong Zhu; Hu Zhao; Yanpu Liu; Jin Su
Journal:  Cancer Biol Ther       Date:  2014-02-20       Impact factor: 4.742

Review 9.  Epithelial-to-mesenchymal transition in thyroid cancer: a comprehensive review.

Authors:  Heewa Shakib; Sadegh Rajabi; Mohammad Hossien Dehghan; Farideh Jalali Mashayekhi; Nahid Safari-Alighiarloo; Mehdi Hedayati
Journal:  Endocrine       Date:  2019-08-04       Impact factor: 3.633

Review 10.  Collagen Prolyl Hydroxylases Are Bifunctional Growth Regulators in Melanoma.

Authors:  Aithne Atkinson; Alexander Renziehausen; Hexiao Wang; Cristiana Lo Nigro; Laura Lattanzio; Marco Merlano; Bhavya Rao; Lynda Weir; Alan Evans; Rubeta Matin; Catherine Harwood; Peter Szlosarek; J Geoffrey Pickering; Colin Fleming; Van Ren Sim; Su Li; James T Vasta; Ronald T Raines; Mathieu Boniol; Alastair Thompson; Charlotte Proby; Tim Crook; Nelofer Syed
Journal:  J Invest Dermatol       Date:  2018-11-16       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.